—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Amneal Pharmaceuticals, Inc. Class A Common Stock（AMRX）— 同类公司组

数据截至2026-10-28 — 评分每个交易日晚间重新计算。分组标准＝首先为共同的Closelook指数成分，其次为行业。Closelook研究日记，不构成投资建议。

Amneal Pharmaceuticals, Inc. Class A Common Stock的Closelook综合评分为56/100，在同类公司组内排名第3位（共7家）——组内评分最高的是Laboratorios Farmaceuticos ROVI（62/100）。

名称综合动量质量估值信号距52周高点
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock56915846ok2.4%
ROVI.MC Laboratorios Farmaceuticos ROVI62337750info28.1%
BHC.TO Bausch Health Companies Inc57817082info12.7%
GALDY GALDERMA GROUP AG56645922info4.3%
IRWD Ironwood Pharmaceuticals Inc56377783warn37.5%
FAGR.BR Fagron NV54575658info5.7%
ALM.MC Almirall S.A.53304663info24.5%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-28

Quick answers

Amneal Pharmaceuticals, Inc. Class A Common Stock在Closelook覆盖范围内的同类公司有哪些？

分组首先基于共同的Closelook指数成分，其次基于行业：Laboratorios Farmaceuticos ROVI (ROVI.MC)、Bausch Health Companies Inc (BHC.TO)、GALDERMA GROUP AG (GALDY)、Ironwood Pharmaceuticals Inc (IRWD)、Fagron NV (FAGR.BR)、Almirall S.A. (ALM.MC)。

AMRX相对同类公司的评分如何？

Amneal Pharmaceuticals, Inc. Class A Common Stock的综合评分为56/100，组内排名第3位（共7家），截至2026-10-28；组内最高综合评分为Laboratorios Farmaceuticos ROVI（62/100）。Closelook评分为研究日记读数，不构成评级或投资建议。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.